Filing search / Fate Therapeutics, Inc. / "Independent" / Page 5

8-K

EX-1.1

zqp7ishdx

8 Jan 21

Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock

4:02pm

8-K

EX-5.1

jhal5

8 Jan 21

Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock

4:02pm

424B5

fp5xxw7t

7 Jan 21

Prospectus supplement for primary offering

5:25pm

424B5

dpii5k jxi

4 Jan 21

Prospectus supplement for primary offering

4:15pm

424B5

z1kbc05u

10 Jun 20

Prospectus supplement for primary offering

12:00am

8-K

EX-5.1

rg1umotzise68bh

9 Jun 20

Fate Therapeutics Announces Proposed Public Offering of Common Stock

9:21pm

8-K

EX-1.1

t5p 0jdue3yi

9 Jun 20

Fate Therapeutics Announces Proposed Public Offering of Common Stock

9:21pm

424B5

rxe2j2

8 Jun 20

Prospectus supplement for primary offering

4:11pm

8-K

zt8 j1bei6

5 May 20

Fate Therapeutics Announces Changes to its Board of Directors

4:03pm

DEFA14A

bm2cq

20 Mar 20

Additional proxy soliciting materials

4:04pm

S-8

EX-5.1

9tnf uajbd33

2 Mar 20

Registration of securities for employees

5:04pm